CI
ALNY icon

Cigna Investments’s Alnylam Pharmaceuticals ALNY Stock Holding History

Cigna Investments’s Portfolio ALNY Stock Details ALNY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$385K Buy
1,278
+48
+4% +$14.5K 0.05% 304
2026
Q1 		$407K Hold
1,230
– – 0.06% 273
2025
Q4 		$490K Hold
1,230
– – 0.07% 235
2025
Q3 		$561K Sell
1,230
-15
-1% -$6.11K 0.08% 214
2025
Q2 		$406K Sell
1,245
-52
-4% -$14.4K 0.07% 274
2025
Q1 		$351K Hold
1,297
– – 0.07% 291
2024
Q4 		$305K Hold
1,297
– – 0.05% 344
2024
Q3 		$357K Sell
1,297
-25
-2% -$6.51K 0.06% 310
2024
Q2 		$321K Sell
1,322
-30
-2% -$4.74K 0.06% 314
2024
Q1 		$202K Buy
1,352
+30
+2% +$5K 0.04% 442
2023
Q4 		$253K Hold
1,322
– – 0.05% 362
2023
Q3 		$235K Hold
1,322
– – 0.05% 365
2023
Q2 		$251K Hold
1,322
– – 0.05% 385
2023
Q1 		$265K Sell
1,322
-36
-3% -$7.57K 0.05% 364
2022
Q4 		$323K Buy
1,358
+23
+2% +$4.91K 0.07% 320
2022
Q3 		$267K Buy
+1,335
New +$255K 0.06% 336
2022
Q2 		– Sell
-1,270
Closed -$207K – 461
2022
Q1 		$207K Buy
+1,270
New +$193K 0.03% 568

Other funds holding ALNY

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $153B AUM 38.14% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Cigna Investments's ALNY Position: Q2 2026 in Review

Cigna Investments increased its Alnylam Pharmaceuticals (ALNY) stake by 3.9% in Q2 2026, buying an estimated $14.5K and bringing the position to 1,278 shares worth $385K. The position accounts for 0.05% of the portfolio, ranked #304.

Cigna Investments first reported a position in ALNY in Q1 2022 and has held it in 17 quarters since. The position peaked at $561K in Q3 2025. 785 funds tracked by Wall St. Rank hold ALNY as of Q2 2026.

  • Cigna Investments held 1,278 shares of Alnylam Pharmaceuticals worth $385K as of Q2 2026.
  • Cigna Investments bought 48 Alnylam Pharmaceuticals shares in Q2 2026, an estimated $14.5K.
  • Alnylam Pharmaceuticals made up 0.05% of Cigna Investments's portfolio in Q2 2026, its #304 holding.
  • Cigna Investments first reported a position in Alnylam Pharmaceuticals in Q1 2022 and has held it in 17 quarters since.
  • Cigna Investments's Alnylam Pharmaceuticals position peaked at $561K in Q3 2025.
  • 785 funds tracked by Wall St. Rank held Alnylam Pharmaceuticals as of Q2 2026.

Based on Cigna Investments's 13F filing for Q2 2026, filed 21 Jul 2026.